Question Everything. See who's reporting it.

Tribunal upholds ₹5.4cr ED attachment on Lucent Drugs

Source: Times of India

The story in brief

The Appellate Tribunal under SAFEMA Act upheld the Enforcement Directorate’s attachment of ₹5.46 crore from Lucent Drugs Pvt Ltd for unauthorised tramadol exports to Pakistan. The tribunal rejected the company’s valuation argument and dismissed its appeal, confirming the ED’s provisional attachment. The case began with an NCB complaint filed in 2022.

NEWXFree on Android and iPhone. Open in NEWX